Statement of Changes in Beneficial Ownership (4)
11 October 2018 - 7:53AM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
WILSON GLYNN
|
2. Issuer Name
and
Ticker or Trading Symbol
TAPIMMUNE INC.
[
TPIV
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__
X
__ Director
_____ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Last)
(First)
(Middle)
5 WEST FORSYTH STREET, SUITE 200
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
10/9/2018
|
(Street)
JACKSONVILLE, FL 32202
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
|
10/9/2018
|
|
A
|
|
31120
(1)
|
A
|
$0
|
189337
|
D
|
|
Common Stock
|
10/9/2018
|
|
F
|
|
7561
(2)
|
D
|
$0
|
181776
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Employee Employment Agreement (right to receive)
|
(3)
|
10/9/2018
|
|
M
|
|
|
31120
|
(3)
|
(3)
|
Common Stock
|
31120
|
$0
|
0
|
D
|
|
Explanation of Responses:
|
(1)
|
Represents issuance of fully vested shares of common stock under the Company's 2014 Omnibus Stock Ownership Plan pursuant to the Company's obligation to do so under the terms of the Reporting Person's employment agreement as amended.
|
(2)
|
Represents withholding of shares of common stock to satisfy tax withholding obligations in connection with the issuance of the stock award.
|
(3)
|
Represents elimination of Reporting Person's right to receive shares under his employment agreement following the issuance of the shares to the Reporting Person reflected on Table I by the Company.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
WILSON GLYNN
5 WEST FORSYTH STREET, SUITE 200
JACKSONVILLE, FL 32202
|
X
|
|
|
|
Signatures
|
/s/ Mark A. Catchur, as Attorney-in-Fact for Glynn Wilson
|
|
10/10/2018
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
TapImmune, Inc. (NASDAQ:TPIV)
Historical Stock Chart
From Oct 2024 to Nov 2024
TapImmune, Inc. (NASDAQ:TPIV)
Historical Stock Chart
From Nov 2023 to Nov 2024
Real-Time news about Marker Therapeutics (delisted) (NASDAQ): 0 recent articles
More Tapimmune Inc. News Articles